Clinical Trials Browser

Prostatic Neoplasms

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Urinary Bladder Neoplasms, Carcinoma in Situ

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Breast Neoplasms

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Metastatic Solid Tumors

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Prostatic Neoplasms

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck

Smoking Cessation, Multiple Pulmonary Nodules

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Colonic Neoplasms, Lymphoma

Carcinoma, Hepatocellular, Liver Cirrhosis

Breast Neoplasms

Gastrointestinal Neoplasms, Head and Neck Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Cancer Diagnosis

Prostatic Neoplasms

Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms

Dementia, Fever of Unknown Origin, Heart Diseases, Osteomyelitis, Vasculitis

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular

Clinical Trials

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

A Study of Patients Receiving High-Dose Rate Brachytherapy

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker

Evaluation of Breast CT

A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

PSMA PET

DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy

PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

FDG-PET in Advanced Melanoma